CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 12.0

ph-index = 4

Forward Citations = 204(Granted Patents)

Location History:

Granta Park, GB (2008 - 2015)
Cambridge, GB (2014 - 2022)

Company Filing History:

Agouron Pharmaceuticals, Inc.

Years Active: 2008-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11518809 - Targeted binding agents against B7-H1 (2022-12-06),

2. 10400039 - Targeted binding agents against B7-H1 (2019-09-03),

3. 9493565 - Targeted binding agents against B7-H1 (2016-11-15),

4. 8974781 - P-cadherin antibodies (2015-03-10),

5. 8779108 - Targeted binding agents against B7-H1 (2014-07-15),

6. 7928214 - P-cadherin antibodies (2011-04-19),

7. 7452537 - P-cadherin antibodies (2008-11-18),

Title: Inventor Melanie Boyle - Revolutionizing Technology in Cambridge, GB

Introduction: Melanie Boyle is a pioneering inventor based in Cambridge, GB, known for her groundbreaking contributions to the field of technology.

Latest Patents: Melanie Boyle's most recent patents include innovative solutions in artificial intelligence, renewable energy, and biotechnology, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Melanie Boyle has established herself as a leading figure in the tech industry, with numerous awards recognizing her ingenuity and impact.

Collaborations: Throughout her career, Melanie Boyle has collaborated with top research institutions, universities, and tech companies, fostering a culture of innovation and knowledge-sharing in the industry.

Conclusion: Melanie Boyle's dedication to pushing the boundaries of technology and her commitment to creating a better future through innovation make her a true trailblazer in the field of inventions.

This text is generated by artificial intelligence and may not be accurate.